Realty Income Has Made 650 Consecutive Monthly Payments and the Streak Looks Secure
247wallst.com
Want to monitor ORIC?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor ORICoric pharmaceuticals, inc. , a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. its lead product candidate is oric-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors.